TCM Biotech International Corp. (TPE:4169)

TCM Biotech International Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-13.8	19.17	21.01	18.57	18.27	1.87
Depreciation & Amortization	21.98	22	22.03	20.2	18.41	16.46
Other Amortization	1.07	1.53	1.84	1.69	1.59	1.59
Loss (Gain) From Sale of Assets	-1.01	-1.08	-0.72	-0.8	-	-0.91
Asset Writedown & Restructuring Costs	0.67	0.67	-	-	-	-
Stock-Based Compensation	29.49	-	-	1.95	-	1.73
Provision & Write-off of Bad Debts	-1.29	-0.65	-0.69	-	0.48	-
Other Operating Activities	-2.54	-0.99	1.33	1.02	6.19	-3.14
Change in Accounts Receivable	-12.8	-18.26	120.47	-27.69	-35.13	-22.2
Change in Inventory	-37.77	-12.72	50.65	-13.34	4.75	-3.27
Change in Accounts Payable	31.44	29.55	-43.32	-18.69	24.47	18.14
Change in Unearned Revenue	13.4	7.45	0.59	2.72	-20.55	1.31
Change in Other Net Operating Assets	0.05	-9.54	-5.76	-23.17	33.77	3.74
Operating Cash Flow	28.9	37.13	167.42	-37.54	52.24	15.33
Operating Cash Flow Growth	-77.94%	-77.82%	-	-	240.86%	-79.54%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-2.08	-2.49	-8	-3.98	-3.78	-4.14
Sale of Property, Plant & Equipment	2.04	2.17	1.28	1.33	-	1.96
Sale (Purchase) of Intangibles	-0.34	-0.34	-0.35	-0.94	-1.51	-3.58
Investment in Securities	-	-	-330	-	-0.09	-
Other Investing Activities	3.4	3.7	-3.32	-0.94	-2.71	-13.85
Investing Cash Flow	3	3.04	-340.4	-4.52	-8.09	-19.61

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	-	44
Long-Term Debt Issued	-	-	-	30	-	-
Total Debt Issued	-	-	-	30	-	44
Short-Term Debt Repaid	-	-	-44	-	-	-
Long-Term Debt Repaid	-	-7.37	-37.09	-72.08	-12.55	-11.94
Total Debt Repaid	-24.87	-7.37	-81.09	-72.08	-12.55	-11.94
Net Debt Issued (Repaid)	-24.87	-7.37	-81.09	-42.08	-12.55	32.06
Issuance of Common Stock	72.83	-	-	500	-	13.09
Common Dividends Paid	-20.67	-20.67	-16.83	-1.62	-	-16.92
Other Financing Activities	-	-	-0.27	-	0.11	-
Financing Cash Flow	27.29	-28.04	-98.19	456.3	-12.44	28.24

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.07	-0.04	0.02	0.04	-0.12	0.03
Net Cash Flow	59.13	12.09	-271.15	414.29	31.59	23.99

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	26.81	34.65	159.42	-41.51	48.46	11.19
Free Cash Flow Growth	-78.24%	-78.27%	-	-	333.15%	-84.45%
Free Cash Flow Margin	3.81%	5.05%	23.92%	-4.28%	6.04%	1.59%
Free Cash Flow Per Share	0.45	0.59	2.70	-0.78	0.99	0.23
Levered Free Cash Flow	-	29.83	146.85	-42.01	63.66	11.11
Unlevered Free Cash Flow	-	30.37	147.85	-40.28	65.15	12.34

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.86	0.86	1.61	2.77	2.39	1.97
Cash Income Tax Paid	4.19	4.12	2.57	2.44	-	3.53
Change in Working Capital	-5.69	-3.52	122.63	-80.18	7.3	-2.28

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error